228760.KQ
Genomictree Inc.
KOE · Healthcare · Biotechnology · KR
KRW 10,510.00
−1.13%Year over year
Reported trailing growth
- Revenue
- -17.1%
- EBITDA
- —
- EBIT
- +8.1%
- EPS
- +1.7%
- Free cash flow
- +18.5%
- Operating cash flow
- +15.7%
Forward estimates
Based on analyst estimates
- Revenue
- +952.1%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -49.9%
- EBITDA
- -14.7%
- EBIT
- +26.2%
- Net income
- +12.3%
- EPS
- +12.7%
- Free cash flow
- +38.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026